Source‐Dependent Mitochondrial Transplantation Drives Schwann Cell Bioenergetic Reprogramming and Peripheral Nerve Regeneration
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiangling Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Schwann Cells, Nerve Regeneration, Mitochondria, Peripheral Nerve Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, CSS program.
Abstract (Originalsprache)
Following peripheral nerve injury (PNI), metabolic reprogramming of Schwann cells (SC) plays a critical role in axonal regeneration and functional recovery. Although mitochondrial transplantation (MT) has been proposed as a potential therapeutic strategy, it remains unclear whether its effect is limited to transient energy supplementation. We systematically compared the differential effects of mitochondria derived from human induced pluripotent stem cells (iPSCs, iP‐MT) and induced mesenchymal stem cells (iMSCs, iM‐MT) on regulating SC metabolism and promoting peripheral nerve regeneration. The results showed that exogenous mitochondria were efficiently taken up by SCs, not only increasing ATP production and mitochondrial membrane potential but also reshaping the metabolic distribution between glycolysis and oxidative phosphorylation. This remodeling promoted cell proliferation, migration, and neurotrophic function, while enhancing antioxidant capacity. In a rat sciatic nerve injury model, MT significantly improved axonal regeneration, remyelination, and the recovery of sensory and motor functions. Notably, iM‐MT demonstrated stronger metabolic adaptability and therapeutic efficacy. MT reduced ROS accumulation, increased ATP production, and attenuated apoptosis under oxidative stress. This study reveals that MT promotes nerve repair by driving metabolic reprogramming rather than merely providing temporary energy, offering a new theoretical basis for optimizing the selection of mitochondrial donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Stem Cell Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Xiangling Li, Yuan Zou, Fatima Aldali, Qiuzhi Zhou
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- CSS program
- National Key Research and Development Program of China
Zitieren
APA
Li, X., Huang, Y., Cao, X., Luo, H., Zou, Y., Aldali, F., Chen, S., Li, Y., Zhou, Q., & Chen, H. (2026). Source‐Dependent Mitochondrial Transplantation Drives Schwann Cell Bioenergetic Reprogramming and Peripheral Nerve Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71495
Vancouver
Li X, Huang Y, Cao X, Luo H, Zou Y, Aldali F, et al. Source‐Dependent Mitochondrial Transplantation Drives Schwann Cell Bioenergetic Reprogramming and Peripheral Nerve Regeneration. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71495
BibTeX
@article{Li2026,
author = {Li, Xiangling and Huang, Yunjie and Cao, Xiaojian and Luo, Hongmei and Zou, Yuan and Aldali, Fatima and Chen, Sheng and Li, Yajie and Zhou, Qiuzhi and Chen, Hong},
title = {Source‐Dependent Mitochondrial Transplantation Drives Schwann Cell Bioenergetic Reprogramming and Peripheral Nerve Regeneration},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71495}
}
EUVIMED